CON Quote, Financials, Valuation and Earnings

Encompass Health Corp. has a net margin of 6.71% compared to Concentra Group Holdings Parent, Inc.'s net margin of 13.07%. Concentra Group Holdings Parent, Inc.'s return on equity of 47.29% beat Encompass Health Corp.'s return on equity of 24.73%.

Concentra Group Holdings Parent, Inc. has a consensus price target of $29.00, signalling upside risk potential of 23.09%. On the other hand Encompass Health Corp. has an analysts' consensus of $142.73 which suggests that it could grow by 31%. Given that Encompass Health Corp. has higher upside potential than Concentra Group Holdings Parent, Inc., analysts believe Encompass Health Corp. is more attractive than Concentra Group Holdings Parent, Inc..

Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.328%.

Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.06%. Encompass Health Corp. offers a yield of 0.66% to investors and pays a quarterly dividend of $0.19 per share. Concentra Group Holdings Parent, Inc. pays 19.54% of its earnings as a dividend. Encompass Health Corp. pays out 13% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentra Group Holdings Parent, Inc. quarterly revenues are $539.1M, which are smaller than Encompass Health Corp. quarterly revenues of $1.5B. Concentra Group Holdings Parent, Inc.'s net income of $36.2M is lower than Encompass Health Corp.'s net income of $201.9M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 18.31x while Encompass Health Corp.'s PE ratio is 19.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.39x versus 1.88x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Elite Health Systems, Inc. has a net margin of 6.71% compared to Concentra Group Holdings Parent, Inc.'s net margin of --. Concentra Group Holdings Parent, Inc.'s return on equity of 47.29% beat Elite Health Systems, Inc.'s return on equity of -72.99%.

Concentra Group Holdings Parent, Inc. has a consensus price target of $29.00, signalling upside risk potential of 23.09%. On the other hand Elite Health Systems, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Concentra Group Holdings Parent, Inc. has higher upside potential than Elite Health Systems, Inc., analysts believe Concentra Group Holdings Parent, Inc. is more attractive than Elite Health Systems, Inc..

Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Elite Health Systems, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.465%.

Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.06%. Elite Health Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent, Inc. pays 19.54% of its earnings as a dividend. Elite Health Systems, Inc. pays out -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentra Group Holdings Parent, Inc. quarterly revenues are $539.1M, which are larger than Elite Health Systems, Inc. quarterly revenues of --. Concentra Group Holdings Parent, Inc.'s net income of $36.2M is higher than Elite Health Systems, Inc.'s net income of -$1.2M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 18.31x while Elite Health Systems, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.39x versus 7.08x for Elite Health Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Pediatrix Medical Group, Inc. has a net margin of 6.71% compared to Concentra Group Holdings Parent, Inc.'s net margin of 6.82%. Concentra Group Holdings Parent, Inc.'s return on equity of 47.29% beat Pediatrix Medical Group, Inc.'s return on equity of 19.95%.

Concentra Group Holdings Parent, Inc. has a consensus price target of $29.00, signalling upside risk potential of 23.09%. On the other hand Pediatrix Medical Group, Inc. has an analysts' consensus of $21.33 which suggests that it could grow by 7.31%. Given that Concentra Group Holdings Parent, Inc. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe Concentra Group Holdings Parent, Inc. is more attractive than Pediatrix Medical Group, Inc..

Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pediatrix Medical Group, Inc. has a beta of 0.786, suggesting its less volatile than the S&P 500 by 21.358%.

Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.06%. Pediatrix Medical Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentra Group Holdings Parent, Inc. pays 19.54% of its earnings as a dividend. Pediatrix Medical Group, Inc. pays out -- of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentra Group Holdings Parent, Inc. quarterly revenues are $539.1M, which are larger than Pediatrix Medical Group, Inc. quarterly revenues of $493.8M. Concentra Group Holdings Parent, Inc.'s net income of $36.2M is higher than Pediatrix Medical Group, Inc.'s net income of $33.7M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 18.31x while Pediatrix Medical Group, Inc.'s PE ratio is 10.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.39x versus 0.89x for Pediatrix Medical Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

U.S. Physical Therapy, Inc. has a net margin of 6.71% compared to Concentra Group Holdings Parent, Inc.'s net margin of 6.45%. Concentra Group Holdings Parent, Inc.'s return on equity of 47.29% beat U.S. Physical Therapy, Inc.'s return on equity of 8.4%.

Concentra Group Holdings Parent, Inc. has a consensus price target of $29.00, signalling upside risk potential of 23.09%. On the other hand U.S. Physical Therapy, Inc. has an analysts' consensus of $105.33 which suggests that it could grow by 26.53%. Given that U.S. Physical Therapy, Inc. has higher upside potential than Concentra Group Holdings Parent, Inc., analysts believe U.S. Physical Therapy, Inc. is more attractive than Concentra Group Holdings Parent, Inc..

Concentra Group Holdings Parent, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison U.S. Physical Therapy, Inc. has a beta of 1.301, suggesting its more volatile than the S&P 500 by 30.094%.

Concentra Group Holdings Parent, Inc. has a quarterly dividend of $0.06 per share corresponding to a yield of 1.06%. U.S. Physical Therapy, Inc. offers a yield of 2.16% to investors and pays a quarterly dividend of $0.45 per share. Concentra Group Holdings Parent, Inc. pays 19.54% of its earnings as a dividend. U.S. Physical Therapy, Inc. pays out 126.62% of its earnings as a dividend. Concentra Group Holdings Parent, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but U.S. Physical Therapy, Inc.'s is not.

Concentra Group Holdings Parent, Inc. quarterly revenues are $539.1M, which are larger than U.S. Physical Therapy, Inc. quarterly revenues of $202.7M. Concentra Group Holdings Parent, Inc.'s net income of $36.2M is higher than U.S. Physical Therapy, Inc.'s net income of $13.1M. Notably, Concentra Group Holdings Parent, Inc.'s price-to-earnings ratio is 18.31x while U.S. Physical Therapy, Inc.'s PE ratio is 58.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentra Group Holdings Parent, Inc. is 1.39x versus 1.62x for U.S. Physical Therapy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.